Genetic variation in targets of roxadustat and risk of common cancers: A Mendelian randomization analysis
Our findings support a potential causal relationship between the inhibition of EGLN1 and EGLN2 and the development of specific cancer types.
Authors
- Wenjie Long (ORCID: https://orcid.org/0000-0002-9849-5077)
- Hongxi Chen (ORCID: https://orcid.org/0000-0002-2814-4511)
- Xin Ma (ORCID: https://orcid.org/0000-0002-0183-4803)
- Xiaona He (ORCID: https://orcid.org/0000-0003-4673-669X)
- Yangang Zhou
- Yue Qi (ORCID: https://orcid.org/0000-0003-1296-2138)
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.5414/cn111790
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00